Maria Evangelia Chatzimina

Dr. Maria Evangelia Chatzimina

ICS, Foundation for Research and Technology Hellas, Heraklion, Greece
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2016 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
Lefteris KoumakisLefteris Koumakis
Lefteris Koumakis
Alexandros KanterakisAlexandros Kanterakis
Alexandros Kanterakis
EKEvgenia Kartsaki
Evgenia Kartsaki
Maria Evangelia ChatziminaMaria Evangelia Chatzimina
Maria Evangelia Chatzimina
MZMichalis Zervakis
Michalis Zervakis
GPGeorge Potamias
George Potamias
Pathway analysis methodologies couple traditional gene expression analysis with knowledge encoded in established molecular pathway networks, offering a promising approach towards the biological interpretation of phenotype differentiating genes. Early pathway analysis methodologies, named as gene set analysis (GSA), view pathways just as plain lists of genes without taking into account either the underlying pathway network topology or the involved gene regulatory relations. These approaches, even if they achieve computational efficiency and simplicity, consider pathways that involve the same genes as equivalent in terms of their gene enrichment characteristics. Most recent pathway analysis approaches take into account the underlying gene regulatory relations by examining their consistency with gene expression profiles and computing a score for each profile. Even with this approach, assessing and scoring single-relations limits the ability to reveal key gene regulation mechanisms hidden in longer pathway sub-paths. We introduce MinePath, a pathway analysis methodology that addresses and overcomes the aforementioned problems. MinePath facilitates the decomposition of pathways into their constituent sub-paths. Decomposition leads to the transformation of single-relations to complex regulation sub-paths. Regulation sub-paths are then matched with gene expression sample profiles in order to evaluate their functional status and to assess phenotype differential power. Assessment of differential power supports the identification of the most discriminant profiles. In addition, MinePath assess the significance of the pathways as a whole, ranking them by their p-values. Comparison results with state-of-the-art pathway analysis systems are indicative for the soundness and reliability of the MinePath approach. In contrast with many pathway analysis tools, MinePath is a web-based system (www.minepath.org) offering dynamic and rich pathway visualization functionality, with the unique characteristic to color regulatory relations between genes and reveal their phenotype inclination. This unique characteristic makes MinePath a valuable tool for in silico molecular biology experimentation as it serves the biomedical researchers’ exploratory needs to reveal and interpret the regulatory mechanisms that underlie and putatively govern the expression of target phenotypes. It is generally recognized that using different sources of information and knowledge is better than just using a single source. This is most profound in the post-genomics era. On one hand, the advent of genomic high-throughput technologies realized by DNA microarray and next generation RNAseq technologies enabled a ‘systems level analyses’ by offering the ability to measure the expression status of thousands of genes in parallel. On the other, molecular pathway networks depict the interaction of DNA segments during the transcription of genes into mRNA. The prominent and vital role of pathways in the study of various biology processes is a major sector in contemporary biology research. We introduce MinePath, a pathway analysis methodology that amalgamates information and knowledge from gene expression profiles and molecular pathways. The novelty of MinePath resides in its ability to target not just the genes involved in the pathways, as most of existing methodologies and tools do, but directly their interrelations and interactions. With this approach, the regulatory machinery that putatively governs and guides the expression of disease phenotypes can be explored and revealed.

21 May 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
Maria Evangelia ChatziminaMaria Evangelia Chatzimina
Maria Evangelia Chatzimina
Helen PapadakiHelen Papadaki
Helen Papadaki
CPCharalampos G. Pontikoglou
Charalampos G. Pontikoglou
Manolis TsiknakisManolis Tsiknakis
Manolis Tsiknakis
In addressing the critical role of emotional context in patient–clinician conversations, this study conducted a comprehensive sentiment analysis using BERT, RoBERTa, GPT-2, and XLNet. Our dataset includes 185 h of Greek conversations focused on hematologic malignancies. The methodology involved data collection, data annotation, model training, and performance evaluation using metrics such as accuracy, precision, recall, F1-score, and specificity. BERT outperformed the other methods across all sentiment categories, demonstrating its effectiveness in capturing the emotional context in clinical interactions. RoBERTa showed a strong performance, particularly in identifying neutral sentiments. GPT-2 showed promising results in neutral sentiments but exhibited a lower precision and recall for negatives. XLNet showed a moderate performance, with variations across categories. Overall, our findings highlight the complexities of sentiment analysis in clinical contexts, especially in underrepresented languages like Greek. These insights highlight the potential of advanced deep-learning models in enhancing communication and patient care in healthcare settings. The integration of sentiment analysis in healthcare could provide insights into the emotional states of patients, resulting in more effective and empathetic patient support. Our study aims to address the gap and limitations of sentiment analysis in a Greek clinical context, an area where resources are scarce and its application remains underexplored.

11 July 2018 in ecancermedicalscience
Verified
Journal Article
Open access
GIGalatia Iatraki
Galatia Iatraki
Haridimos KondylakisHaridimos Kondylakis
Haridimos Kondylakis
Lefteris KoumakisLefteris Koumakis
Lefteris Koumakis
Maria Evangelia ChatziminaMaria Evangelia Chatzimina
Maria Evangelia Chatzimina
EKEleni Kazantzaki
Eleni Kazantzaki
Manolis TsiknakisManolis Tsiknakis
Manolis Tsiknakis
Ecancermedicalscience is the peer-reviewed open access cancer journal founded by the European Institute of Oncology in Milan. We consider articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epide

1 October 2019
Verified
Conference Paper
Closed access
Maria Evangelia ChatziminaMaria Evangelia Chatzimina
Maria Evangelia Chatzimina
LKLefteris Koumakis
Lefteris Koumakis
Kostas MariasKostas Marias
Kostas Marias
MTManolis Tsiknakis
Manolis Tsiknakis
Recording of patient-reported outcomes (PROs) enables direct measurement of the experiences of patients with chronic conditions, including cancer; thus, PROs are a critical element of high quality, person-centered care for cancer patients. A growing body of literature reports on the feasibility of using electronic tools for the collection of Patient reported Outcomes (ePROs), although the usability of available solutions does affect their acceptance and use. In parallel, recent advancement in artificial intelligence, machine learning and speech recognition have led to the growing interest in conversational agents, i.e. software applications that mimic written or spoken human speech. In the present manuscript we provide a review of current developments regarding the implementation of conversational agents and their application in the domain of palliative care for oncology patients and also present (i) a methodology for the implementation of a conversational agent able to collect ePRO health data and (ii) initial evaluation results from a relevant feasibility study. Our approach differs from other available systems since the conversational agent reported in the present work is not based on rules, but rather uses machine learning algorithms and more specifically recurrent neural networks (RNN) for identifying appropriate answers. Evaluation results of user experience provided promising results and highlight that users gave positive responds when interacting with the system. Based on the User Experience Questionnaire, pragmatic quality and overall quality were categorized as excellent and hedonic quality was categorized as good. The result of this research can be used as reference for the future development and improvement of the conversational agents in the healthcare domain.

17 November 2017
Verified
Book Chapter
Closed access
PDF file
Lefteris KoumakisLefteris Koumakis
Lefteris Koumakis
HKH. Kondylakis
H. Kondylakis
DKD. G. Katehakis
D. G. Katehakis
GIG. Iatraki
G. Iatraki
PAP. Argyropaidas
P. Argyropaidas
Kostas MariasKostas Marias
Kostas Marias

30 July 2025 in International Journal of Medical Informatics
Verified
Journal Article
Open access
Maria Evangelia ChatziminaMaria Evangelia Chatzimina
Maria Evangelia Chatzimina
HPHelen A. Papadaki
Helen A. Papadaki
CPCharalampos Pontikoglou
Charalampos Pontikoglou
Manolis TsiknakisManolis Tsiknakis
Manolis Tsiknakis
Conversations in clinical settings, especially those involving hematologic cancers or palliative care are not only informational but also emotionally charged. Understanding how these conversations are structured could help develop AI systems that support not only information exchange but also personalized emotional care. This study explored the themes discussed and emotional tones in real conversations between Greek speaking clinicians and patients. Our aim was to contribute toward building digital tools for low-resource languages such as Greek that are not only linguistically appropriate but also emotionally aware. We analyzed over 52,000 anonymized utterances from real Greek clinical conversations using BERTopic for topic modeling and a domain-specific sentiment classifier fine-tuned on Greek medical data. Topics were labeled using both a large language model (Gemma-3) and extractive keyword methods (KeyBERT). The analysis revealed 35 thematic clusters, covering areas like symptoms, diagnosis, emotional states, treatment choices, and end-of-life planning. Sentiment analysis revealed that patients expressed more negative sentiment in utterances related to pain, uncertainty or personal loss. Clinicians often responded with a more neutral or even empathetic positive tone, especially when offering support or medical advice. Our findings show that Natural Language Processing (NLP) can reveal both the content and emotional tone of conversations in medical settings. This approach could support the development of digital health tools such as conversational agents that are more emotionally aware in Greek and other low-resource languages, especially in emotionally charged domains like palliative care.